Livestreaming Platform Supported by:

custom image custom image custom image

32nd Annual North American Cystic Fibrosis Conference

SC04--CLIN-INF/MIC-NRS: Optimization of Antibiotics in Emerging Pathogens

Oct 17, 2018 3:30pm ‐ Oct 17, 2018 7:30pm


Description

Experts will discuss the use of oral, inhaled, and intravenous antibiotics for challenging pathogens that are encountered in CF: MRSA, Pulmonary Non-tuberculous mycobacteria (NTM), multi-drug resistant (MDR) Pseudomonas aeruginosa, B. cepacia complex, Stenotrophomonas maltophilia, and Achromobacter species. In addition, we will discuss the diagnosis and management of allergic bronchopulmonary aspergillosis (ABPA). The session will be practical with a focus on the approach to actual CF patients and the nuances of individual cases will be discussed. Handouts will be provided with dosing and clinical scenarios to consider oral, inhaled, and intravenous antibiotics for these pathogens.

Learning Objectives:

  • Create an approach to asymptomatic, new MRSA infection as well as the outpatient management of chronic symptomatic MRSA infection.
  • Explain the importance of multiple antibiotics as well as discuss options and approach for the treatment of MDR gram negative infections.
  • Design & assess therapeutic options of pulmonary NTM and ABPA infections.

Short Course Leader(s):

Short Course Speaker(s):

You must be logged in and own this session in order to post comments.